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Abstract
Background: ADHD is currently defined as a cognitive/behavioral developmental disorder where all clinical
criteria are behavioral. Overactivity, impulsiveness, and inattentiveness are presently regarded as the main clinical
symptoms. There is no biological marker, but there is considerable evidence to suggest that ADHD behavior is
associated with poor dopaminergic and noradrenergic modulation of neuronal circuits that involve the frontal
lobes. The best validated animal model of ADHD, the Spontaneously Hypertensive Rat (SHR), shows pronounced
overactivity, impulsiveness, and deficient sustained attention. While dopamine release is decreased in SHR,
norepinephrine concentrations are elevated. The primary objective of the present research was to test effects of
a range of doses of the catecholamine agonists d- and l-amphetamine on ADHD-like symptoms in SHR.
Methods: The present study tested behavioral effects of 0.64 to 1.91 mg/kg d-amphetamine; and 1.27 to 3.81
mg/kg l-amphetamine base/kg i.p. in male SHRs and their controls, the Wistar Kyoto rat (WKY). ADHD-like
behavior was tested with a visual discrimination task measuring overactivity, impulsiveness and inattentiveness.
Results: The striking impulsiveness, overactivity, and poorer sustained attention during baseline conditions in the
SHR were improved by treatment with the amphetamine isomers. The dose-response curves were, however,
different for the different behaviors. Most significantly, d-amphetamine reduced overactivity and impulsiveness
more efficiently than comparable doses of l-amphetamine. The lowest dose of d-amphetamine and low-to-
medium doses of l-amphetamine improved sustained attention. The highest dose of d-amphetamine used
interfered with SHR behavior. A second study showed that the impaired sustained attention (percent correct
lever choice) in the SHR was not due to impaired visual functions or poorer working memory.
Discussion: The present results indicate that overactivity and impulsiveness may to some extent be associated
with imbalances in neural circuits that differ from those causing poor sustained attention and that the two
amphetamine isomers may affect the different neuromodulators differently. While d-amphetamine improved SHR
overactivity, impulsiveness as well as sustained attention, the behavioral effects of l-amphetamine were relatively
more specific for improving sustained attention than for the other 2 symptoms. Thus, while d- and l-amphetamine
affect similar neuronal systems their relative potencies may be different.
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Attention-deficit/hyperactivity disorder (ADHD) is cur-
rently defined as a cognitive developmental disorder
where all clinical criteria are behavioral [1]. Overactivity,
impulsiveness, and inattentiveness are presently regarded
as the main clinical symptoms.
There have been many attempts to explain the origins of
ADHD symptoms. A dual-process theory [2-5] suggests
that less efficient reinforcement processes and deficient
extinction of previously reinforced behavior may explain
behavioral changes often described as response disinhibi-
tion [6] or poor executive functions [7].
ADHD is highly heritable and the genetic and neurobio-
logical causes are likely to reside in brain catecholamines
(for a review see [4]). Most likely, ADHD symptoms are
associated with reduced post-synaptic efficacy of
dopaminergic and noradrenergic modulation of neuronal
circuits that involve the frontal lobes [8,9]. Imaging of stri-
atal neuronal networks indicates reduced dopamine effi-
cacy in ADHD [10]. Further, noradrenergic systems are
involved in attention processes and prime prefrontal areas
for response to sensory stimuli [11]. It is therefore not sur-
prising that amphetamines and other catecholamine ago-
nists have been the drugs of choice in medication of
ADHD [8,9,12-14].
Recent neuropharmacological studies have shown that d-
and l-amphetamine may affect electrically stimulated
dopamine and norepinephrine release differently [15].
Thus, the two amphetamine isomers may affect the vari-
ous receptors and neuromodulators of the central nervous
system differently.
The spontaneously hypertensive rat (SHR) is the best val-
idated animal model of ADHD. These rats show hyperac-
tivity, impulsiveness and deficits in sustained attention
[9,16-18]. The control strain is usually the Wistar Kyoto
Rat (WKY) as this rat is the progenitor strain and its behav-
ior is closely similar to that of other strains when tested in
well-controlled operant tasks [17]. Drugs used in the
pharmacological treatment of ADHD, usually catecho-
lamine agonists have been shown to reduce ADHD-like
behavior in this model [16,19-21]. The primary objective
of the present research was to test effects of a range of
doses of the catecholamine agonists d- and l-ampheta-
mine on ADHD-like symptoms in SHR. It is predicted that
d-amphetamine in particular should improve the ADHD-
like behavior of the SHR.
Study 1: Comparison of amphetamine isomers 
on sustained attention, overactivity and 
impulsiveness
The present study investigated behavioral effects of d- and
l-amphetamine in an animal model of ADHD.
Methods
Subjects
A total number of 32 male rats, 16 SHR and 16 WKY, par-
ticipated in this study. At the start of testing following 8
days acclimatization, the rats were 5 wk old and experi-
mentally naïve. Young rats were required, as ADHD pri-
marily is a child and adolescent disorder. The SHRs were
obtained from Charles River Italy (SHR/Crl Ico) and the
WKYs from Charles River France (WKY/Nico).
At the University of Oslo, the rats were housed individu-
ally in 41 × 25 × 25 (height) cm transparent cages and had
free access to food (RM3 (E) from Special Diet Services,
Witham, Essex CM8 3AD, UK). The rats had access to
water at all times before the habituation session. Starting
following completion of the habituation session, the rats
were deprived of water for 21 hr a day; this is a moderate,
but sufficient deprivation for motivating the animal. The
temperature in the housing area was ~22°C. The light was
on from 0700 to 1900 hours. The behavioral training took
place between 1000 and 1330 hours seven days a week.
The study was approved by the Norwegian Animal
Research Authority (NARA), and was conducted in
accordance with the laws and regulations controlling
experiments/procedures in live animals in Norway.
Behavioral apparatus
Sixteen Campden Instruments operant chambers were
used in the study. The animal working space in eight of
the chambers was 25 × 25 × 30 (height) cm and 25 × 25 ×
20 (height) cm in the other eight chambers. A fan produc-
ing a low masking noise and the 2.8-W house light were
on during the entire experimental session.
During training sessions, either one or both retractable
levers were used (below). A 2.8-W cue light was located
above each lever. The rats' response consisted of pressing
one of the levers with a dead weight of at least 3 g to acti-
vate a micro-switch. The reinforcers (0.01 ml tap water)
were delivered by a liquid dipper located in a small
recessed cubicle with a 2.8-W cue light that lit up when a
reinforcer was presented. A 7 × 5 cm transparent plastic lid
separated the cubicle from the rat's working space. The rat
could easily open the lid with a light push with the nose
or paw. Each chamber was ventilated and placed in a
sound-resistant outer housing. A computer and an online
system (SPIDER, Paul Fray, Ltd., UK) recorded the behav-
ior and scheduled reinforcers (drops of water).Page 2 of 12
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chamber (1 through 16) and time of testing (1000 or
1200 hours) in a randomized and balanced way. The rat
was returned to its living cage after each session and
immediately given free access to water for 90 min.
Response acquisition
The training period started with a single 30-min habitua-
tion session. During the habituation session, the lid
between the working space and the reinforcement cubicle
was kept open. The house light was on, but no lever was
present, no cue light above any lever was lit and water was
not delivered.
The habituation session was followed by two 30-min dip-
per training sessions. The lid was taped open, no levers
were present, and the house light was on, but the cue
lights above the levers were not lit. The computer deliv-
ered water on the average every 10 s independent of the
rat's behavior (a variable-time schedule). Each water
delivery was accompanied by the turning on of the cue
light in the small recessed cubicle.
In the next two sessions, the rat was trained to open the lid
to gain access to the water. The lid was not taped open, no
levers were present and the lights above the levers were
not activated. The house light was on. Each lid opening
was followed by a presentation of a single drop of water.
The cue light in the recessed cubicle was turned on when
water was present.
During the subsequent two sessions, lever responding was
shaped by the method of successive approximations [22].
During the first of these sessions, the rats learned to press
the left lever in order to receive a reinforcer immediately
following every press. The cue light above the left lever
was now lit the entire session. The right lever was retracted
into the wall and the light above the right lever was off.
On the second session, the right lever was activated and
the left lever retracted. During this session the light above
the right lever was lit the entire session. The house light
was on during both sessions. Following this shaping pro-
cedure, the animal had acquired the appropriate lever-
pressing behavior.
From now on, both levers were present. The light above
the levers shifted randomly. The light stayed lit above a
lever for as long as it was the correct lever. This was the dis-
criminative stimulus showing the rat which lever it had to
press in order to receive a reinforcer. A concurrent extinc-
tion schedule was present on the wrong lever. There was
never any light above the extinction lever. Thus, the
present task was a simultaneous visual discrimination
task. The first four of these sessions lasted for 30 min and
the reinforcers were delivered following every correct lever
press. Then followed a single session when the reinforcers
were delivered according to a 15-s random-interval sched-
ule. Whenever an interval had elapsed, the reinforcer was
delivered immediately following the first correct response.
Final schedule
The simultaneous visual discrimination task was used for
testing effects of the drugs. An unpredictable 180-s ran-
dom-interval schedule was in effect for 90 min on the cor-
rect lever (signaled by a constantly lit cue light above this
lever) from session 13 on until the study was finished.
Inter-reinforcer times ranged from 6 to 719 s in a rand-
omized fashion with a skewed distribution modeled after
the "Harvard golden tape" [23]. There was neither any
external stimulus signaling that a reinforcer was pro-
grammed, nor any external stimulus signaling the time
since the last response. A concurrent extinction schedule
(never associated with any cue light) was present on the
wrong lever. The house light was lit the entire session.
Behavioral measures
Each session was divided into five 18-min segments
(parts) in order to monitor intra-session changes in the
behavior. For each segment, total number of presses on
the correct and incorrect lever as well as number of rein-
forcers delivered were recorded. Time between consecu-
tive correct responses (inter-response time, IRT) was also
recorded.
The total number of lever presses is an expression of the
general activity level and therefore a measure of degree of
activity. The percent choice of the correct lever when the
reinforcers are delivered infrequently is a measure of sus-
tained attention. The number of responses with short IRTs
(<0.67 s) is used as a measure of degree of impulsiveness
(cannot hold back a response even when one knows it is
an unnecessary one).
Drug administration
Administration of the drugs started at session 49 when the
behavior had stabilized. The two isomers of amphetamine
were compared with vehicle and with each other. All rats
received d-amphetamine sulphate and l-amphetamine
sulphate. The dosing was balanced in the initial schedule.
The schedule was later extended to take into account
results obtained by session 76 (Drug day 9). This involved
repeating some of the previous results when the previous
ones had deviated from what was predicted and adding
new doses that the obtained data suggested might be of
interest: 0.64 mg/kg d-amphetamine and 1.27 mg/kg l-
amphetamine. Each rat was injected intraperitoneally at a
dose volume of 1 ml/kg body weight of the animal ~30
min before testing, with either vehicle (physiological
saline) or drug. Drugs were administered every 3rd or 4thPage 3 of 12
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design.
Drugs
D-amphetamine sulphate (Lot 031298) and l-ampheta-
mine sulphate (Lot FB-101-57) were supplied from Boer-
inger-Ingelheim US. Doses were 0.64, 1.27, and 1.91 mg/
kg for d-amphetamine; and 1.27, 2.54, and 3.81 mg/kg
for l-amphetamine. Doses were calculated as the weight of
base using a conversion factor of 1.360 mg sulphate salt as
equivalent to 1.000 mg base. Doses were based on pilot
studies. Dosing solutions were prepared as a solution in
physiological saline. Stock solutions, 1.91 mg/kg for d-
amphetamine; and 3.81 mg/kg for l-amphetamine, were
prepared at the start of the dosing period and kept at +4 to
+6°C when not in use. Dilutions of the stock solutions
were made each day of dosing.
Data management and statistical procedures
The mean behavior was regarded as the drug response,
and dose-response curves were plotted for each drug and
strain. The data were processed by univariate and multi-
variate analyses of variance (ANOVAs and MANOVAs,
respectively) with the Statistica 7.1 program [24]. Isomer
and dose are within-subject variables. Strain is a between-
subject variable. One control rat was identified as a statis-
tical outlier with Grubbs' Test [25,26]. Post-hoc compari-
sons following MANOVAs were performed by the
Unequal N HSD procedure, a generalization of Tukey's
test to the case of unequal samples sizes (see [27], p. 975).
Results
General
Compared to WKY controls, SHRs showed pronounced
overactivity, impulsiveness and poorer sustained atten-
tion. The drugs gave clear dose-response curves in the
SHRs. The dose-response curves were different for the dif-
ferent behaviors. Low to medium doses of d- and l-
amphetamine improved sustained attention. SHR overac-
tivity and impulsiveness were reduced more by d-amphet-
amine than by l-amphetamine. Following the highest
dose, d-amphetamine interfered with SHR behavior dur-
ing the first part of the sessions.
Acquisition
As is the case in children with ADHD [28,29], the symp-
toms developed with time, but differently for the different
behaviors [18]. The final schedule was installed on ses-
sion 13. A pronounced overactivity was seen in SHRs from
this session on (see Additional files 1 and 2). SHR impul-
siveness, responding within 0.67 s since the previous lever
press although such a lever press was almost never rein-
forced, continued to increase in the SHR throughout the
entire study [18]. This measure was accompanied by
increased variability over days during the course of the
study, something that is typical in ADHD [30-32]. Impul-
siveness was subjected to a log10-transformation in order
to obtain the more equal variances required by the ANO-
VAs.
Effects of drugs
Overactivity
The pronounced SHR overactivity was reduced by both
drugs (Figure 1). Following the highest doses of either
drug, the general activity level of the SHR approached that
of the WKY, more so after the highest doses of d-amphet-
amine than after l-amphetamine. The highest dose of d-
amphetamine reduced SHR behavior early in the session
below WKY levels. This result indicates severely drugged
Effects of d-amphetamine (left) and l-amphetamine (right) on total number of lever presses (correct plus incorrect) by SHR and WKY c ntrolsFigure 1
Effects of d-amphetamine (left) and l-amphetamine (right) on total number of lever presses (correct plus incorrect) by SHR and 
WKY controls. Means ± SEM.Page 4 of 12
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fected by the drugs at these doses.
The ANOVA showed a statistically significant main effect
of strain (F(1,28) = 28.52, p < 0.001). The MANOVA
showed statistically significant interactions between strain
× drug (F(1,28) = 28.44, p < 0.001), strain × dose, and
strain × drug × dose (Fs(3,26) > 5.78, ps < 0.004). The 3-
way interaction indicating that d-amphetamine reduced
SHR hyperactivity more efficiently than l-amphetamine
following the doses used. Post-hoc comparisons showed
that all three doses of both d- and l-amphetamine reduced
SHR overactivity (ps < 0.002). No dose or drug altered
WKY activity level (ps > 0.3).
Impulsiveness
SHRs showed a pronounced impulsiveness that was
reduced by both drugs. Following d-amphetamine, SHR
impulsiveness was more affected than WKY impulsive-
ness. l-Amphetamine, however, produced similar effects
in both strains (Figure 3). Except for the two highest doses
of d-amphetamine producing more pronounced effects
early in the session, particularly in SHRs, the other doses
produced fairly stable effects throughout the session (Fig-
ure 4).
The ANOVA showed a statistically significant main effect
of strain (F(1,28) = 7.79, p < 0.01). The MANOVA showed
statistically significant interactions between strain × drug
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on number of lever pres es (correct plus incorr ct) by SHR and WKY co trolsFigur  2
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on 
number of lever presses (correct plus incorrect) by SHR and WKY controls. Means ± SEM.
Effects of d-amphetamine (left) and l-amphetamine (right) on impulsiveness, responding within 0.67 s following the previous lev r press, of SHR and WKY controls following log10 ransformationFigure 3
Effects of d-amphetamine (left) and l-amphetamine (right) on impulsiveness, responding within 0.67 s following the previous 
lever press, of SHR and WKY controls following log10 transformation. Means ± SEM.Page 5 of 12
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drug × dose (Fs(3,26) > 6.54, ps < 0.002). The 3-way inter-
action indicating that d-amphetamine reduced SHR
impulsiveness more efficiently than l-amphetamine fol-
lowing the doses used. Post-hoc comparisons showed that
the two highest doses of both d- and l-amphetamine
reduced SHR impulsiveness (ps < 0.005). The highest d-
amphetamine dose and the two highest l-amphetamine
doses reduced WKY responding (ps < 0.001).
Sustained attention
Without medication, SHRs showed poorer sustained
attention than WKY controls. In contrast to the effects on
activity and impulsiveness, where the most pronounced
effects were seen following the highest doses of d-amphet-
amine, sustained attention appeared to improve in the
SHR following low-to-medium doses only (Figure 5).
The ANOVA showed a statistically significant main effect
of strain (F(1,28) = 5.25, p < 0.03). The MANOVA showed
no strain × drug, nor any 3-way strain × drug × dose inter-
action (Fs(1,28) < 2.3, ps > 0.1). There was however, a
Effects of d-amphetamine (left) and l-amphetamine (right) on sustained attention, choice of the correct lever in percent of all lev r presses, by SHR and WKY controlsFigure 5
Effects of d-amphetamine (left) and l-amphetamine (right) on sustained attention, choice of the correct lever in percent of all 
lever presses, by SHR and WKY controls. Means ± SEM.
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on impul-siveness, responding within 0.67 s following the previous lever pr ss, of SHR and WKY controls following log10 transf rmationFigure 4
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on impul-
siveness, responding within 0.67 s following the previous lever press, of SHR and WKY controls following log10 transforma-
tion. Means ± SEM.Page 6 of 12
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results indicate that both drugs affected sustained atten-
tion similarly with the doses used. A more detailed
within-session analysis showed however that especially
the highest dose of d-amphetamine disrupted behavior
early in the session (Figure 6) while there was no such dis-
ruption following l-amphetamine. Post-hoc comparisons
showed that the 0.64 mg/dose of d-amphetamine and the
1.27 and 2.54 mg/kg doses of l-amphetamine signifi-
cantly improved sustained attention in SHR (ps < 0.001).
These improvements lasted the entire session (Figure 6).
No dose or drug improved sustained attention in WKY,
but the 3.81 mg/kg l-amphetamine made it significantly
worse (p < 0.001).
Reinforcers delivered
The random-interval reinforcement schedule used was
programmed so that even large individual differences in
lever pressing would result in approximately 6 reinforcers
(drops of water) during each 18-min segment of the ses-
sion, even for the case of the less active strain. A major
advantage of such a schedule is the fact that systematic
strain differences in thirst should not be of concern when
interpreting the other data.
The results show that both strains in general received 6
reinforcers each segment. However, following the 1.91
mg/kg d-amphetamine dose, the SHR strain was unable to
maintain a sufficient response output during the initial 36
min to deliver the 12 reinforcers programmed (Figure 7).
These reinforcers were, however, delivered during the last
36 min, thereby in effect producing an unintended RI 90
s schedule of reinforcement.
Stereotypy and severely drugged behavior
The 1.91 mg/kg d-amphetamine dose apparently pro-
duced a severely drugged behavior in the SHR during the
two initial 18-min segments of the session. l-Ampheta-
mine, on the other hand, never produced such an effect in
any of the animals.
Discussion
Study 1 investigated behavioral effects of d- and l-amphet-
amine on activity, impulsiveness and sustained attention
in an animal model of ADHD. Overall, SHR behaviors
were improved. The amphetamines affected these behav-
iors differently. The results showed clearer dose-response
curves in the SHR than in the WKY strain. d-Amphetamine
was more than twice as potent as l-amphetamine in reduc-
ing SHR hyperactivity and impulsivity. Low-to-medium
doses of d- and l-amphetamine, improved sustained
attention in the SHR while the highest dose did not. The
highest doses reduced hyperactivity and impulsiveness. It
is, however, likely that the highest dose of d-ampheta-
mine caused severely drugged behavior in the SHR during
the initial half of the session. Thus, only low-to-medium
doses produced what might be regarded as real improve-
ments in behavior.
Study 2: No visual discrimination or memory 
problems in the SHR
Study 1 showed reduced percentage choice of the correct
lever in SHRs when the reinforcers were delivered accord-
ing to a random-interval 180 s schedule lasting 90 min
(see also Figure 2 in [18]). Results of previous studies
[33,34], indicate that there is an impaired sustained atten-
tion in the SHR. The main objective of Study 2 was to sub-
stantiate that the reduced percent correct lever choice in
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on sus-tained attention, choice of the correct l ver in perce t of all lever presses, by SHR and WKY controlsFigure 6
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on sus-
tained attention, choice of the correct lever in percent of all lever presses, by SHR and WKY controls. Means ± SEM.Page 7 of 12
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to poorer visual functions or problems with remembering
the presentation of the discriminative stimulus (i.e.,
poorer "working memory").
Procedure
Subjects
Eight experimentally naïve spontaneously hypertensive
(SHR/NHsd) and 8 Wistar/Kyoto (WKY/NHsd) served as
subjects. They were ~40 days old, weighted 170–250 g, at
the start of the study. The animals were obtained from the
Harlan UK Ltd., Bicester, England. Feeding and housing
were similar to that in Study 1.
Behavioral apparatus
Eight of the Campden Instruments operant chambers
from the previous study were used.
Before initiation of the study, the rats were assigned a
chamber (1 through 8) and time of testing (0830 or 1000
hours) in a randomized and balanced way. They were run
Mondays through Fridays. The rat was returned to its liv-
ing cage after each session and immediately given free
access to water for 45 min.
Response acquisition
The initial training was similar to that used in Study 1. A
single 30-min habituation session was followed by two
30-min dipper training sessions and two sessions when
water was delivered whenever the rat opened the lid into
the recessed cubicle. During the next session, responding
on the left lever was shaped by the method of successive
approximations [22]. This was followed by two 30-min
sessions stabilizing responding by reinforcing each press
on the left lever. The cue light above the left lever was now
lit the entire session. The right lever was not available dur-
ing these sessions. During the next session, responding on
the right lever was shaped in the same way as responding
on the left. Then, the light above the right lever was lit the
entire session. Following this shaping procedure the ani-
mal had acquired the appropriate behavior.
From now on, both levers were present. The discrimina-
tive stimulus light above the levers shifted randomly fol-
lowing each trial showing the rat which lever it had to
press to obtain a reinforcer. The rat received the reinforcer
immediately after pressing the correct lever. A concurrent
extinction schedule, never associated with the cue light or
a reinforcer, was present on the wrong lever.
After response acquisition, a 15-s random-interval sched-
ule was in effect on the signaled correct lever for fifteen
21-min sessions in order to stabilize behaviors before start
of the experiment.
Final schedule
Visual functions and working memory were tested during
the next 62 sessions each lasting 24 min. A fixed ratio 1
schedule was in effect on the correct lever during these ses-
sions. During this schedule, a reinforcer is delivered fol-
lowing every correct response.
There was no light above any of the two retracted levers at
the start of a trial. Then the discriminative stimulus light
above one of the two levers was lit for 5 s showing that this
lever was going to be the correct one during this trial. Both
levers were presented at the same time. Initially, levers
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on number of rei forcer delivered to SHR and WKY controlsFigur  7
Within-session effects of d-amphetamine (the two panels to the left) and l-amphetamine (the two panels to the right) on 
number of reinforcers delivered to SHR and WKY controls. Means ± SEM.Page 8 of 12
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between light and lever was 4 s) (Table 1).
The light was turned off and both levers retracted imme-
diately after the rat had pressed a lever. A reinforcer was
delivered immediately if the rat had chosen the correct
lever. Pressing the wrong lever never produced any rein-
forcer. After a 2 s intertrial interval, one cue light would be
lit and the two levers would be presented again.
The time relation between presentation of the discrimina-
tive stimulus and lever presence was changed every five
sessions until there was a 2 s delay from when the discrim-
inative stimulus was turned off to insertion of the levers.
Then extra sessions had to be given because the rats
needed more training to reach a stable percentage correct
lever choice (Table 1). The behavior during the final three
sessions of stable performance of each discriminative
stimulus-lever presence condition was used in the data
analyses. Finally, 14 sessions were run with a 4 s overlap
in order to check for any change in baseline behavior.
Results
Percent correct
The percent correct lever choice decreased in both SHR
and WKY by decreasing overlap between the discrimina-
tive stimulus and the presentation of the levers (Figure 8).
The MANOVA showed a significant main effect of this
overlap (F(7,8)= 16.10, p < 0.001), but neither any signif-
icant main effect of strain (F (1,14) = 0.26, p > 0.5), nor
any interaction involving strain (ps > 0.1).
Total number of trials
The total number of trials during the 24-min session
decreased in both SHR and WKY by decreasing overlap
between the discriminative stimulus and response lever
presence. There was neither any significant main effect of
strain (F(1,14) > 0.8, p > 0.3), nor any interaction involv-
ing strain (ps > 0.1).
Reestablishment of baseline
Baseline behavior was successfully reestablished. The
MANOVA showed no significant within-strain effects
when baseline (the first five sessions) and reestablishment
(the last ten sessions) were compared: the percent correct
lever choice (ps > 0.5), and the number of correct
responses, (ps >0.3).
Discussion
There was no strain difference in percent correct lever
choice when the levers were made available during the
presence of the discriminative stimulus. This result means
that SHR had no visual problems. Further, both strains
started at the same baseline and the percent correct lever
choice declined at the same rate by decreasing overlap
between the discriminative stimulus and the presentation
of the levers (Figure 8). Thus, information the rats used for
choosing the levers decayed at the same rate in SHR as in
WKY control rats. Finally, the successful reestablishment
of baseline behavior at the end of the study showed that
the relation between percent correct lever choice and time
from turning off the discriminative stimulus to the presen-
tation of the levers was not related to the number of ses-
sions run, training, or aging.
In conclusion, Study 2 showed that the reduced percent
correct lever choice in SHR when reinforcers are few as in
the Study 1 as well as previously published studies [18,20]
may be described as poorer sustained attention and not
visual problems or problems with remembering the loca-
tion of the discriminative stimulus (working memory).
Choice of the correct lever in percent of all lever presses by SHR and WKY contro s as function of decreasing ov rlapbetwe n the dis iminative stimulus an  the pr sentation of the leversFigur  8
Choice of the correct lever in percent of all lever presses by 
SHR and WKY controls as function of decreasing overlap 
between the discriminative stimulus and the presentation of 
the levers. Means ± SEM.
Table 1: Experimental design of Study 2
Session no. 42–46 47–51 52–56 57–66 67–71 72–81 82–90 91–104
Overlap/delay 4 s 2 s 0 s -2 s -3 s -4 s -5 s 4 sPage 9 of 12
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ADHD is currently defined as a cognitive/behavioral
developmental disorder where all clinical criteria are
behavioral. Overactivity, impulsiveness, and inattentive-
ness are presently regarded as the main clinical symptoms
[1]. These symptoms have been operationalized in a long
series of translational research investigating ADHD
behavior in children and animal models [29-32,35,36].
The present Study 2 showed that the reduced percent cor-
rect lever choice frequently observed in SHR [18,20], is
due to poorer sustained attention, not to poorer visual
functions or poorer working memory.
ADHD is highly heritable and the genetic and neurobio-
logical causes are likely to reside in reduced postsynaptic
effects of catecholamines on glutamatergic and GABAergic
neurons [4]. These changes apparently cause less efficient
reinforcement processes and deficient extinction of previ-
ously reinforced behavior [3-5].
Amphetamines and other dopamine agonists have been
the drugs of choice in medication of ADHD [8,9,12-14].
The present research investigated behavioral effects of
doses of d-and l-amphetamine isomers. The dose-
response curves were different for the different behaviors.
These drugs improved SHR behavior as predicted. Most
significantly, low-to-medium doses of both amphetamine
isomers improved sustained attention, medium-to-high
doses of d-amphetamine reduced overactivity and impul-
siveness more efficiently than medium-to-high doses of l-
amphetamine.
Although there seems to be an altered dopamine receptor
1 and 5 (DRD1/DRD5) neurotransmission in the SHR
within the frontal-striatal circuitry involved in motor con-
trol [37], the present results may imply that ADHD is
associated with a more general monoamine dysfunction
than just a dopamine dysfunction alone [4]. It has been
suggested that aspects of ADHD behavior result from
imbalances between noradrenergic and dopaminergic reg-
ulation of neural circuits that involve the prefrontal cortex
[9,11,38,39]. The present results indicate that overactivity
and impulsiveness, at least to some degree, are caused by
imbalances in neural circuits that differ from those caus-
ing poor sustained attention and that the two ampheta-
mine isomers may affect the different neuromodulators
differently. In fact, while d-amphetamine showed effects
that seem to be relatively specific to the SHR, in that it
reduced overactivity, impulsiveness and improved sus-
tained attention, l-amphetamine showed a relatively
greater effect in improving sustained attention compared
with its effect on reducing overactivity and impulsiveness.
This is perhaps reminiscent of the effects of the alpha-2a
adrenoceptor agonist guanfacine which produced quite
similar effects in both SHR and WKY [20]. This conclusion
may be in general agreement with recent neuropharmaco-
logical results showing that d- and l-amphetamine may
affect electrically stimulated dopamine and norepine-
phrine release somewhat differently [15].
Finally, it is reason to believe that the inefficient reinforce-
ment and extinction processes related to ADHD give rise
to the variable and unpredictable behavior associated
with ADHD [4]. Future studies of the dynamics of behav-
ior [31,32] will tell us if the apparent normalization of
arithmetic means seen in the present as well as other stud-
ies, is associated with normalization of the organization
of behavior following medication.
In conclusion, overactivity and impulsiveness in SHR may
primarily be associated with reduced efficacy of dopamine
functions causing inefficient reinforcement and extinction
processes [2-5], while the poorer sustained attention may
to some extent be associated with reduced efficacy of nore-
pinephrine (despite the increased norepinephrine release
normally seen in the SHR [9,40]).
Competing interests
This research was in part financially supported by Shire
Pharmaceutical Development LTD, England (Company
No. 2486738), Hampshire International Business Park,
Chineham, Basingstoke, Hampshire RG24 8EP, Great
Britain. The company had no role, however, in the presen-
tation of the research. Data presentation, statistics, discus-
sion and conclusions that are the authors' own
responsibility.
Authors' contributions
TS designed the studies, ran Study 1 and wrote the manu-
script. TX ran pilot studies leading up to Study 1 and per-
formed Study 2. Both authors approved the final
manuscript.
Additional material
Additional file 1
The video shows a normal male WKY control rat performing the visual 
discrimination task.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1744-
9081-4-3-S1.wmv]
Additional file 2
The video shows a Spontaneously Hypertensive Rat (SHR) performing the 
visual discrimination task. The rat is overactive and inattentive.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1744-
9081-4-3-S2.wmv]Page 10 of 12
(page number not for citation purposes)
Behavioral and Brain Functions 2008, 4:3 http://www.behavioralandbrainfunctions.com/content/4/1/3Acknowledgements
Some of this research was financially supported by Shire Pharmaceutical 
Development LTD, England (Company No. 2486738), Hampshire Interna-
tional Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, Great 
Britain. The research was also supported by grants from the University of 
Oslo and by The Centre for Advanced Study at the Norwegian Academy 
of Science and Letters, Drammensveien 78, NO-0271 Oslo, Norway. TX 
was supported by the National Educational Foundation of Norway, Grant 
No. 97-1704456. We are also grateful to Ms. Grete Wøien for her invalu-
able help in running the studies and to Dr. Geir Sagvolden for writing the 
programs controlling the on-line system running the operant chambers and 
collecting the data. Expert technical services were provided by Trond Rep-
pen and Bjarne Authen.
References
1. Association AP: Diagnostic and statistical manual of mental disorders:
DSM-IV 4th edition. Washington, D.C., Author; 1994:78-85. 
2. Sagvolden T, Archer T: Future perspectives on ADD research -
- An irresistible challenge.  In Attention deficit disorder: Clinical and
basic research Edited by: Sagvolden T and Archer T. Hillsdale, N.J.,
Lawrence Erlbaum Associates; 1989:369-389. 
3. Johansen EB, Aase H, Meyer A, Sagvolden T: Attention-deficit/
hyperactivity disorder (ADHD) behaviour explained by dys-
functioning reinforcement and extinction processes.  Behav
Brain Res 2002, 130:37-45.
4. Sagvolden T, Johansen EB, Aase H, Russell VA: A dynamic develop-
mental theory of Attention-Deficit/Hyperactivity Disorder
(ADHD) predominantly hyperactive/impulsive and com-
bined subtypes.  Behav Brain Sci 2005, 28:397-419.
5. Johansen EB, Sagvolden T, Aase H, Russell VA: The dynamic devel-
opmental theory of attention-deficit/hyperactivity disorder
(ADHD): Present status and future perspectives.  Behav Brain
Sci 2005, 28:451-454.
6. Barkley RA: Behavioral inhibition, sustained attention, and
executive functions: constructing a unifying theory of
ADHD.  Psychol Bull 1997, 121:65-94.
7. Tannock R: Attention deficit hyperactivity disorder: advances
in cognitive, neurobiological, and genetic research.  J Child Psy-
chol Psychiatry 1998, 39:65-99.
8. Arnsten AF, Dudley AG: Methylphenidate improves prefrontal
cortical cognitive function through alpha2 adrenoceptor and
dopamine D1 receptor actions: Relevance to therapeutic
effects in Attention Deficit Hyperactivity Disorder.  Behav
Brain Funct 2005, 1:2.
9. Russell VA, Sagvolden T, Johansen EB: Animal models of atten-
tion-deficit hyperactivity disorder.  Behav Brain Funct 2005, 1:9.
10. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM: DOPA
decarboxylase activity in attention deficit hyperactivity dis-
order adults. A [fluorine-18]fluorodopa positron emission
tomographic study.  J Neurosci 1998, 18:5901-5907.
11. Arnsten AFT, Li BM: Neurobiology of executive functions: cat-
echolamine influences on prefrontal cortical functions.  Biol
Psychiatry 2005, 57:1377-1384.
12. Biederman J, Spencer T, Wilens T: Evidence-based pharmaco-
therapy for attention-deficit hyperactivity disorder.  Int J Neu-
ropharmacol 2004, 7:77-97.
13. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothen-
berger A: Non-stimulant medications in the treatment of
ADHD.  Eur Child Adolesc Psychiatry 2004, 13:102-116.
14. Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G:
Influence of methylphenidate on brain development - an
update of recent animal experiments.  Behav Brain Funct 2006,
2:2.
15. Easton N, Steward C, Marshall F, Fone K, Marsden C: Effects of
amphetamine isomers, methylphenidate and atomoxetine
on synaptosomal and synaptic vesicle accumulation and
release of dopamine and noradrenaline in vitro in the rat
brain.  Neuropharmacology 2007, 52:405-414.
16. Sagvolden T: The spontaneously hypertensive rat as a model
of ADHD.  In Stimulant drugs and ADHD: Basic and clinical neuroscience
Edited by: Solanto MV, Arnsten AFT and Castellanos FX. New York,
Oxford University Press; 2001:221-237. 
17. Sagvolden T: Behavioral validation of the spontaneously
hypertensive rat (SHR) as an animal model of attention-def-
icit/hyperactivity disorder (AD/HD).  Neurosci Biobehav Rev
2000, 24:31-39.
18. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M: Rodent
models of attention-deficit/hyperactivity disorder.  Biol Psychi-
atry 2005, 57:1239-1247.
19. Sagvolden T, Metzger MA, Schiørbeck HK, Rugland AL, Spinnangr I,
Sagvolden G: The spontaneously hypertensive rat (SHR) as an
animal model of childhood hyperactivity (ADHD): changed
reactivity to reinforcers and to psychomotor stimulants.
Behav Neural Biol 1992, 58:103-112.
20. Sagvolden T: The alpha-2A adrenoceptor agonist guanfacine
improves sustained attention and reduces overactivity and
impulsiveness in an animal model of Attention-Deficit/
Hyperactivity Disorder (ADHD).  Behav Brain Funct 2006, 2:41.
21. Wultz B, Sagvolden T, Moser EI, Moser MB: The spontaneously
hypertensive rat as an animal model of attention-deficit
hyperactivity disorder: effects of methylphenidate on explor-
atory behavior.  Behav Neural Biol 1990, 53:88-102.
22. Catania AC: Learning 4th edition. N.J., Englewoods Cliffs, Prentice
Hall; 1998. 
23. Catania AC, Reynolds GS: A quantitative analysis of the
responding maintained by interval schedules of reinforce-
ment.  J Exp Anal Behav 1968, 11:Suppl:327-Suppl:383.
24. StatSoft: Statistica for Windows.  2005 [http://www.statsoft.com].
Tulsa, OK: StatSoft, Inc.
25. Grubbs F: Procedures for detecting outlying observations in
samples.  Technometrics 1969, 11:1-21.
26. Stefansky W: Rejecting outliers in factorial designs.  Technomet-
rics 1972, 14:469-479.
27. Spjotvoll E, Stoline MR: An extension of the T-method of multi-
ple comparison to include the cases with unequal sample
sizes.  J Am Stat Assoc 1973, 68:975-978.
28. Sleator EK, Ullman RK: Can a physician diagnose hyperactivity
in the office?  Pediatrics 1981, 67:13-17.
29. Sagvolden T, Aase H, Zeiner P, Berger DF: Altered reinforcement
mechanisms in Attention-Deficit/Hyperactivity Disorder.
Behav Brain Res 1998, 94:61-71.
30. Aase H, Sagvolden T: Infrequent, but not frequent, reinforcers
produce more variable responding and deficient sustained
attention in young children with attention-deficit/hyperac-
tivity disorder (ADHD).  J Child Psychol Psychiatry 2006,
47:457-471.
31. Aase H, Sagvolden T: Moment-to-moment dynamics of ADHD
behaviour.  Behav Brain Funct 2005, 1:12.
32. Aase H, Meyer A, Sagvolden T: Moment-to-moment dynamics of
ADHD behaviour in South African children.  Behav Brain Funct
2006, 2:11.
33. Sagvolden T, Hendley ED, Knardahl S: Behavior of hypertensive
and hyperactive rat strains: Hyperactivity is not unitarily
determined.  Physiol Behav 1992, 52:49-57.
34. Sagvolden T, Pettersen MB, Larsen MC: Spontaneously hyperten-
sive rats (SHR) as a putative animal model of childhood
hyperkinesis: SHR behavior compared to four other rat
strains.  Physiol Behav 1993, 54:1047-1055.
35. Sagvolden T, Wultz B, Moser EI, Moser MB, Mørkrid L: Results from
a comparative neuropsychological research program indi-
cate altered reinforcement mechanisms in children with
ADD.  In Attention deficit disorder: Clinical and basic research Edited by:
Sagvolden T and Archer T. Hillsdale, N.J., Lawrence Erlbaum Associ-
ates; 1989:261-286. 
36. Sagvolden T, Sergeant JA: Attention deficit/hyperactivity disor-
der--from brain dysfunctions to behaviour.  Behav Brain Res
1998, 94:1-10.
37. Diaz Heijtz R, Castellanos FX: Differential effects of a selective
dopamine D1-like receptor agonist on motor activity and c-
fos expression in the frontal-striatal circuitry of SHR and
Wistar-Kyoto rats.  Behav Brain Funct 2006, 2:18.
38. Russell VA: Hypodopaminergic and hypernoradrenergic activ-
ity in prefrontal cortex slices of an animal model for atten-
tion-deficit hyperactivity disorder --- the spontaneously
hypertensive rat.  Behav Brain Res 2002, 130:191-196.
39. Russell VA, de Villiers A, Sagvolden T, Lamm M, Taljaard J: Altered
dopaminergic function in the prefrontal cortex, nucleus
accumbens and caudate-putamen of an animal model ofPage 11 of 12
(page number not for citation purposes)
Behavioral and Brain Functions 2008, 4:3 http://www.behavioralandbrainfunctions.com/content/4/1/3Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Attention- Deficit Hyperactivity Disorder - the spontane-
ously hypertensive rat.  Brain Res 1995, 676:343-351.
40. Russell V, Allie S, Wiggins T: Increased noradrenergic activity in
prefrontal cortex slices of an animal model for attention-def-
icit hyperactivity disorder--the spontaneously hypertensive
rat.  Behav Brain Res 2000, 117:69-74.Page 12 of 12
(page number not for citation purposes)
